Based on the Vitura Health Limited stock forecast from 0 analysts, the average analyst target price for Vitura Health Limited is not available over the next 12 months. Vitura Health Limited’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Vitura Health Limited is Slightly Bullish , which is based on 8 positive signals and 4 negative signals. At the last closing, Vitura Health Limited’s stock price was AUD 0.08. Vitura Health Limited’s stock price has changed by -6.25% over the past week, -23.47% over the past month and -71.15% over the last year.
No recent analyst target price found for Vitura Health Limited
No recent average analyst rating found for Vitura Health Limited
Company Overview Vitura Health Limited
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a medicinal cannabis clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; and Adaya which provides hybrid formulations and Australian-cultivated products. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. Vitura Health Limited was incorporated in 2018 and is based in South Yarra, Australia. Read Less
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and ...Read More
Frequently Asked Questions About Vitura Health Limited (VIT:AU) Stock
Stock Target Advisor's fundamental analysis for Vitura Health Limited's stock is Slightly Bullish .
Unfortunately we do not have enough data on VIT:AU's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on VIT:AU's stock to indicate what its average analyst target is.
VIT:AU stock's Price/Earning ratio is 9.80.
Our analysis grades VIT:AU stock's Price / Earning ratio at A+. This means that VIT:AU stock's Price/Earning ratio is above 0% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the AU exchange.
Based on this VIT:AU may be undervalued for its sector.
The last closing price of VIT:AU's stock was AUD 0.08.
The most recent market capitalization for VIT:AU is AUD 0.06B.
Unfortunately we do not have enough analyst data on VIT:AU's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Vitura Health Limited's stock.
As per our most recent records Vitura Health Limited has 0 Employees.
Vitura Health Limited's registered address is Suite 8, Level 3, South Yarra, VIC, Australia, 3141.
You can get more information about it from Vitura Health Limited's website at https://vitura.com.au.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Vitura Health Limited (VIT:AU) Stock
Stock Target Advisor's fundamental analysis for Vitura Health Limited's stock is Slightly Bullish .
Unfortunately we do not have enough data on VIT:AU's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on VIT:AU's stock to indicate what its average analyst target is.
VIT:AU stock's Price/Earning ratio is 9.80.
Our analysis grades VIT:AU stock's Price / Earning ratio at A+. This means that VIT:AU stock's Price/Earning ratio is above 0% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the AU exchange.
Based on this VIT:AU may be undervalued for its sector.
The last closing price of VIT:AU's stock was AUD 0.08.
The most recent market capitalization for VIT:AU is AUD 0.06B.
Unfortunately we do not have enough analyst data on VIT:AU's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Vitura Health Limited's stock.
As per our most recent records Vitura Health Limited has 0 Employees.
Vitura Health Limited's registered address is Suite 8, Level 3, South Yarra, VIC, Australia, 3141.
You can get more information about it from Vitura Health Limited's website at https://vitura.com.au.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for VIT:AU !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
